An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments
Sign Up to like & getrecommendations! Published in 2019 at "Oncotarget"
DOI: 10.18632/oncotarget.27343
Abstract: Targeted therapies are playing an increasing role in oncology. Among them, particular attention is nowadays reserved to histology-agnostic treatments. Rare molecular alterations affecting different neoplastic forms, such as Microsatellite Instability (MSI), Neurotropic Tyrosine Receptor Kinase… read more here.
Keywords: rare molecular; detection rare; agnostic treatments; strategy detection ... See more keywords